 BURLINGAME, Calif., March 25, 2021 GLOBE NEWSWIRE -- Corvus Pharmaceuticals, Inc. Nasdaq: CRVS, a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the fourth quarter and year ended December 31, 2020. 